CLASS II ONGOING Device recall · Reported 20 Nov 2019 · FDA Enforcement Report

Infinity M300 telemetry monitoring device recalled

Draegar Medical Systems is recalling Infinity M300 telemetry monitoring device, distributed nationwide in the US. The recall was initiated on 9 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll systems using Software version VG2.3.1 and lower
Quantity recalled12204

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0372-2020
FDA event ID
84028
Recalling firm
Draegar Medical Systems, Andover, MA
Classification
Class II
Status
Ongoing
Recall initiated
9 Oct 2019
FDA classified
14 Nov 2019
Reported
20 Nov 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

9 Oct 2019Recall initiated by company
14 Nov 2019Classified by FDA+36 days
20 Nov 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The devices have potential cybersecurity vulnerabilities, which can include Distributed Denial of Service (DDoS), Spoofing, and Tampering.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Infinity M300 telemetry monitoring device Software versions VG2.3.1 and lower, Model Numbers MS25755, MS26076, MS26031, MS18623, MS22862, MS25301

Where it was distributed

US nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The devices have potential cybersecurity vulnerabilities, which can include Distributed Denial of Service (DDoS), Spoofing, and Tampering.

Which lots are affected?

All systems using Software version VG2.3.1 and lower

Where was it sold?

US nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Draegar Medical Systems

All 13

Other Patient Monitors recalls

All 1,013